KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Tax Assets Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Zimmer Biomet Holdings (ZBH) Notes Payables (2022)

Zimmer Biomet Holdings has reported Notes Payables over the past 4 years, most recently at $83.0 million for Q4 2022.

For Q4 2022, Notes Payables changed N/A year-over-year to $83.0 million; the TTM value through Dec 2022 reached $83.0 million, changed N/A, while the annual FY2022 figure was $83.0 million, N/A changed from the prior year.
Notes Payables for Q4 2022 was $83.0 million at Zimmer Biomet Holdings, up from $500000.0 in the prior quarter.
Over five years, Notes Payables peaked at $83.0 million in Q4 2022 and troughed at $83.0 million in Q4 2022.